| | Saudi MERS response hobbled by institutional failings | RIYADH/LONDON (Reuters) - When Saudi Arabia announced last week it had found 113 more cases of the deadly Middle East Respiratory Syndrome (MERS), it didn't just force a rethink of the threat the virus poses, it exposed institutional failings. | | | Shire agrees to test its ADHD drug in preschool children | LONDON (Reuters) - London-listed drugmaker Shire PLC said it had agreed to a request from the U.S. regulator to test the use of its amphetamine-based drug Vyvanse in preschool children aged four and five with hyperactivity. | | | | FDA lifts partial hold on study testing Geron's only drug | (Reuters) - Geron Corp said the U.S. Food and Drug Administration had lifted a partial clinical hold on a study testing its sole drug as a treatment for myelofibrosis, a rare form of blood cancer, sending the company's shares soaring in early trading. | | | | | | FDA aims to develop e-cigarette standards; nicotine policy | WASHINGTON (Reuters) - The U.S. Food and Drug Administration is working to develop strong product standards for electronic cigarettes and other nicotine delivery devices that will protect public health and enable the agency to withstand legal challenges, its tobacco chief said on Wednesday. | | | | New psych ward to open on California's death row : report | SACRAMENTO Calif. (Reuters) - Under pressure to improve mental health treatment for inmates in California's massive prison system, officials plan to build a new psychiatric ward to provide inpatient mental health care for prisoners on death row, according to a court-ordered report. | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment